Status:
COMPLETED
NOsocomial Dissemination Risk of SARS-Cov2
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Sars-CoV2
Eligibility:
All Genders
Brief Summary
To date, in France, in the context of the SARS Cov2 pandemic,both the number of affected subjects and the number of severe forms requiring hospital care are increasing. Several nosocomial transmissio...
Detailed Description
It is an observational study without any risk. Every participating service will be investigated for 2 consecutive days . * At each staff rotation, an individualsensorwill be provided toall thestaff(c...
Eligibility Criteria
Inclusion
- Inclusion Criteria for patients:
- Informed of the purpose of the study and having expressed his non-opposition or of a relative (if the patient's state of health does not allow it)
- Hospitalized in one of the participating departments
- Inclusion criteria for hospital staff:
- Informed of the objective of the study and having expressed his no opposition
- Having daily contact with patients hospitalized in participating departments
- Inclusion criteria for patient visitors
- Informed of the purpose of the study and having expressed his non-opposition
- Having daily contacts with patients hospitalized in the participating departments
- Exclusion Criteria for evryone (patient, hospital staff and patients visitors) :
- Refuse to participate
Exclusion
Key Trial Info
Start Date :
April 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 12 2020
Estimated Enrollment :
2523 Patients enrolled
Trial Details
Trial ID
NCT04339881
Start Date
April 17 2020
End Date
July 12 2020
Last Update
November 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Didier Guillemot
Garches, France